
Hemazide O 300mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Azacitidine (300mg)
Overview Hemazide O 300mg Tablet
Trimyel 300mg tablets are indicated in the management of certain hematological malignancies. Specifically, they're employed in adult patients across all Myelodysplastic Syndrome (MDS) subtypes. The physician may prescribe this medication for other conditions as well. Trimyel 300mg tablets can be administered with or without food, but consistent daily timing is recommended. Dosage and frequency are determined by your doctor, depending on your condition and may be adjusted. Adhere strictly to your doctor's instructions; improper use or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue use only under your doctor's guidance. Commonly reported side effects include emesis, asthenia, nausea, and pyrexia. Report any concerning symptoms to your physician; management strategies may be available. Vaccination during treatment requires prior consultation with your doctor. Regular hematological monitoring, along with assessment of hepatic, renal, and cardiac function, is crucial. Prior to commencing treatment, disclose any pre-existing hepatic or renal impairment, and all other medications, particularly anti-infectives, to your doctor. Interactions with numerous other drugs are possible; full disclosure of your medication regimen is essential. This medication is contraindicated during gestation and lactation.
Uses of Hemazide O 300mg Tablet
Myelodysplastic syndromes: Hematological malignancy management
Major Benefits of Hemazide O 300mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 300mg Hemazide O Tablet whole; avoid chewing, crushing, or fracturing it. While food is not mandatory, consistent timing is recommended for optimal results.
Common Side effects of Hemazide O 300mg Tablet:
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Hemazide O 300mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 300mg Hemazide O Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Hemazide O 300mg Tablet works:
Leukemia patients may be prescribed Hemazide O 300mg tablets, an antineoplastic agent. Its mechanism involves disrupting the DNA and RNA synthesis within cancerous cells, thereby inducing cell death and facilitating the healthy development of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hemazide O 300mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Hemazide O 300mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and the use of Hemazide O 300mg tablets are incompatible due to potential infant toxicity indicated by available evidence.
DrivingUNSAFE
Driving ability may be impaired by side effects, including fatigue, associated with Hemazide O 300mg Tablets.
KidneyCAUTION
Patients with kidney impairment should use Hemazide O 300mg Tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver disease should exercise caution when using Hemazide O 300mg tablets, potentially requiring dosage modification under medical supervision. Hemazide O 300mg tablets are contraindicated for individuals with advanced hepatic malignancy.
What if you forget to take Hemazide O 300mg Tablet :
NA
Facts to Know About Hemazide O 300mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic inhibitors |
